Skip to content
OpenCapital
Get started

LENZ Therapeutics, Inc. LENZ Q1 2026 earnings

Reported May 11, 2026 · After market close

Revenue$1.9MBeat by $142.1K
EPS-$1.32Miss by $0.22
Revenue estimate$1.8M
EPS estimate-$1.10

Next report

Jul 29, 2026 (Today)
Revenue estimate$2.4M
EPS estimate-$1.05

Versus estimates

Revenue

Q1 2026$1.9MBeat by $142.1K
Q4 2025$1.6MMiss by $1.5MQ3 2025$12.5MBeat by $9.5MQ2 2025$5.0MBeat by $4.3M

Diluted EPS

Q1 2026-$1.32Miss by $0.22
Q4 2025-$1.16Miss by $0.25Q3 2025-$0.59Beat by $0.08Q2 2025-$0.53Beat by $0.05Q1 2025-$0.53Beat by $0.02Q4 2024-$0.46Miss by $0.04

Ask the moment LENZ Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did LENZ Therapeutics, Inc. report Q1 2026 earnings?
LENZ Therapeutics, Inc. (LENZ) reported Q1 2026 earnings on May 11, 2026 after market close.
What were LENZ Therapeutics, Inc.'s Q1 2026 revenue and EPS?
LENZ Therapeutics, Inc. reported revenue of $1.9M and eps of $-1.32 for Q1 2026.
Did LENZ Therapeutics, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $1.8M by $142.1K. EPS missed the consensus estimate of $-1.10 by $0.22.
How did LENZ Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 149.1% from $-0.53.
Where can I find LENZ Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001815776-26-000035) and the 10-Q periodic report (0001815776-26-000037) directly on SEC EDGAR. The filing index links above go to sec.gov.